APEX1 and neoplasm: Recent work using APE1C65A redox-deficient mutants has demonstrated that selective impairment of APE1’s redox function reduces tumor growth and metastasis in PDAC models in vivo (25), establishing the precedent for studying APE1’s dual functions independently.